Explore detailed financial insights for NSE: Sumitomo Chemical India Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Sumitomo Chemical India Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Sumichem, including updates on board meetings and corporate actions.

SUMICHEM
Sumitomo Chemical India Limited - https://www.sumichem.co.in
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company exports its products. Sumitomo Chemical India Limited was incorporated in 2000 and is headquartered in Mumbai, India. The company is a subsidiary of Sumitomo Chemical Company Limited.

Sumitomo Chemical India Limited Share Price Today

503.50
OPEN
530.00
HIGH
503.50
LOW
519.40
CLOSE
2,654 K
VOLUME
25,674 Cr
Market Cap
489083
Average Volume
Basic Materials
Sector
NSI
Exchange

Sumitomo Chemical India Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: SUMICHEM Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Sumitomo Chemical India Limited
SUMICHEM
INE258G01013
Dividend - Re 0.90 Per Share
19 Jul 2024
10
N/A
Sumitomo Chemical India Limited
SUMICHEM
INE258G01013
Special Interim Dividend - Rs 5 Per Share
14 Feb 2024
10
N/A
Sumitomo Chemical India Limited
SUMICHEM
INE258G01013
Dividend - Rs 1.20 Per Share
21 Jul 2023
10
N/A
Sumitomo Chemical India Limited
SUMICHEM
INE258G01013
Dividend - Re 1 Per Sh
21 Jul 2022
10
N/A
Sumitomo Chemical India Limited
SUMICHEM
INE258G01013
Dividend - Rs 0.80 Per Share
22 Jul 2021
10
N/A

NSE: SUMICHEM Recent Announcements

Symbol
Date
Description
Industry
SUMICHEM
01 Jan 2025, 16:40:20
Updates
N/A
SUMICHEM
12 Dec 2024, 12:02:59
Loss/Duplicate-Share Certificate-XBRL
N/A
SUMICHEM
12 Dec 2024, 12:01:52
Loss of Share Certificates
N/A
SUMICHEM
29 Nov 2024, 12:42:30
General Updates
N/A
SUMICHEM
27 Nov 2024, 17:33:49
Loss/Duplicate-Share Certificate-XBRL
N/A

NSE: SUMICHEM Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Sumitomo Chemical India Limited
SUMICHEM
04 Oct 2024, 16:08:00
04 Oct 2024, 16:08:00
Sumitomo Chemical India Limited
SUMICHEM
09 Jul 2024, 17:16:00
09 Jul 2024, 17:16:00
Sumitomo Chemical India Limited
SUMICHEM
05 Apr 2024, 12:11:00
05 Apr 2024, 12:30:00
Sumitomo Chemical India Limited
SUMICHEM
05 Jan 2024, 11:45:00
05 Jan 2024, 12:15:00
Sumitomo Chemical India Limited
SUMICHEM
06 Oct 2023, 17:46:00
05 Feb 2025, 19:32:54

NSE: SUMICHEM Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Independent Director,Chairperson & Non-Executive Director
17 Dec 1943
27 Aug 2019
00047673
MUKUL GOVINDJI ASHER
Active
Executive Director
22 Jul 1954
01 Sep 2019
00488127
CHETAN SHANTILAL SHAH
Active
Executive Director
02 Dec 1951
01 Sep 2019
07618601
SUSHIL CHAMPAKLAL MARFATIA
Active
Executive Director
12 Jun 1969
01 Jun 2023
03110244
SURESH RAMACHANDRAN
Active
Independent Director
16 Apr 1936
27 Aug 2019
00001823
BHUPENDRANATH BHARGAVA
Inactive

NSE: SUMICHEM Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
SUMITOMO CHEMICAL INDIA LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .
SUMICHEM
N/A
INE258G01013
Sumitomo Chemical India Limited
08 Oct 2024, 09:03:53
SUMITOMO CHEMICAL INDIA LIMITED has informed the Exchange about Board Meeting to be held on 27-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .
SUMICHEM
N/A
INE258G01013
Sumitomo Chemical India Limited
05 Jul 2024, 09:23:51
Financial Results/Dividend
SUMICHEM
N/A
INE258G01013
Sumitomo Chemical India Limited
06 May 2024, 15:19:08
Financial Results
SUMICHEM
N/A
INE258G01013
Sumitomo Chemical India Limited
08 Jan 2024, 11:17:02
SUMITOMO CHEMICAL INDIA LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .
SUMICHEM
N/A
INE258G01013
Sumitomo Chemical India Limited
27 Oct 2023, 17:34:09

NSE: SUMICHEM Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
SUMICHEM
-
INE258G01013
Sumitomo Chemical India Limited
06 Jan 2025, 00:00:00
To consider and approve the financial results for the period ended December 31, 2024
Financial Results
SUMICHEM
-
INE258G01013
Sumitomo Chemical India Limited
07 Oct 2024, 00:00:00
To consider inter-alia the Standalone and Consolidated Unaudited Financial Results for the quarter and half-year ended 30th September, 2024.
Financial Results
SUMICHEM
-
INE258G01013
Sumitomo Chemical India Limited
03 Jul 2024, 00:00:00
To consider and approve the financial results for the period ended Jun 30, 2024
Financial Results/Dividend
SUMICHEM
-
INE258G01013
Sumitomo Chemical India Limited
06 May 2024, 00:00:00
To consider and approve the financial results for the period ended March 31, 2024 and dividend
Financial Results
SUMICHEM
-
INE258G01013
Sumitomo Chemical India Limited
08 Jan 2024, 00:00:00
To consider and approve the financial results for the period ended December 31, 2023

NSE: SUMICHEM Balance Sheet Data In (Cr)

date period_type Ordinary Shares Number Share Issued Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Minority Interest Stockholders Equity Other Equity Interest Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Non Current Pension And Other Postretirement Benefit Plans Non Current Deferred Taxes Liabilities Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Provisions Current Liabilities Other Current Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Dividends Payable Total Tax Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Prepaid Assets Non Current Deferred Taxes Assets Investmentin Financial Assets Held To Maturity Securities Available For Sale Securities Financial Assets Designatedas Fair Value Through Profitor Loss Goodwill And Other Intangible Assets Other Intangible Assets Goodwill Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Land And Improvements Properties Current Assets Other Current Assets Hedging Assets Current Restricted Cash Prepaid Assets Inventory Other Inventories Finished Goods Work In Process Raw Materials Other Receivables Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 499,145,736.00 499,145,736.00 288,950,000.00 26,272,670,000.00 27,139,210,000.00 20,679,890,000.00 26,272,670,000.00 284,770,000.00 27,135,030,000.00 27,135,030,000.00 27,167,190,000.00 32,160,000.00 27,135,030,000.00 22,143,570,000.00 0.00 0.00 4,991,460,000.00 4,991,460,000.00 11,258,950,000.00 794,080,000.00 0.00 243,970,000.00 192,270,000.00 192,270,000.00 357,840,000.00 10,464,870,000.00 501,640,000.00 96,680,000.00 92,500,000.00 4,180,000.00 0.00 92,360,000.00 5,299,880,000.00 0.00 0.00 396,080,000.00 4,903,800,000.00 38,426,140,000.00 7,281,380,000.00 37,930,000.00 0.00 16,300,000.00 71,200,000.00 0.00 71,200,000.00 0.00 862,360,000.00 257,950,000.00 604,410,000.00 4,850,160,000.00 0.00 4,850,160,000.00 85,130,000.00 4,765,030,000.00 0.00 0.00 0.00 0.00 31,144,760,000.00 1,115,080,000.00 0.00 0.00 0.00 5,642,900,000.00 0.00 0.00 0.00 0.00 1,719,670,000.00 9,445,000,000.00 0.00 0.00 13,222,110,000.00 12,691,160,000.00 530,950,000.00 0.00 0.00
2024-03-31T00:00:00 quarterly 499,145,736.00 499,145,736.00 302,490,000.00 23,545,550,000.00 24,420,730,000.00 18,721,570,000.00 23,545,550,000.00 297,430,000.00 24,415,670,000.00 24,415,670,000.00 24,445,420,000.00 29,750,000.00 24,415,670,000.00 590,000.00 2,237,920,000.00 2,350,600,000.00 4,991,460,000.00 4,991,460,000.00 8,687,260,000.00 680,230,000.00 258,800,000.00 236,300,000.00 185,130,000.00 185,130,000.00 0.00 8,007,030,000.00 531,840,000.00 117,360,000.00 112,300,000.00 5,060,000.00 104,260,000.00 104,260,000.00 4,899,830,000.00 587,950,000.00 6,110,000.00 5,280,000.00 4,300,490,000.00 33,132,680,000.00 6,404,080,000.00 28,400,000.00 158,400,000.00 7,440,000.00 1,150,000.00 0.00 1,150,000.00 0.00 870,120,000.00 247,660,000.00 622,460,000.00 4,981,880,000.00 -2,335,920,000.00 7,317,800,000.00 39,670,000.00 250,310,000.00 4,737,530,000.00 1,267,360,000.00 1,022,930,000.00 0.00 26,728,600,000.00 997,950,000.00 2,310,000.00 1,366,880,000.00 2,771,120,000.00 6,104,120,000.00 278,800,000.00 3,512,570,000.00 343,930,000.00 1,968,820,000.00 414,380,000.00 7,159,130,000.00 -987,600,000.00 8,146,730,000.00 8,910,660,000.00 8,444,300,000.00 466,360,000.00 112,700,000.00 353,660,000.00
2024-03-31T00:00:00 annual 499,145,736.00 499,145,736.00 302,490,000.00 23,545,550,000.00 24,420,730,000.00 18,721,570,000.00 23,545,550,000.00 297,430,000.00 24,415,670,000.00 24,415,670,000.00 24,445,420,000.00 29,750,000.00 24,415,670,000.00 590,000.00 2,237,920,000.00 2,350,600,000.00 4,991,460,000.00 4,991,460,000.00 8,687,260,000.00 680,230,000.00 258,800,000.00 236,300,000.00 185,130,000.00 185,130,000.00 0.00 8,007,030,000.00 531,840,000.00 117,360,000.00 112,300,000.00 5,060,000.00 104,260,000.00 104,260,000.00 4,899,830,000.00 587,950,000.00 6,110,000.00 5,280,000.00 4,300,490,000.00 33,132,680,000.00 6,404,080,000.00 28,400,000.00 158,400,000.00 7,440,000.00 1,150,000.00 0.00 1,150,000.00 0.00 870,120,000.00 247,660,000.00 622,460,000.00 4,981,880,000.00 -2,335,920,000.00 7,317,800,000.00 39,670,000.00 250,310,000.00 4,737,530,000.00 1,267,360,000.00 1,022,930,000.00 0.00 26,728,600,000.00 997,950,000.00 2,310,000.00 1,366,880,000.00 2,771,120,000.00 6,104,120,000.00 278,800,000.00 3,512,570,000.00 343,930,000.00 1,968,820,000.00 414,380,000.00 7,159,130,000.00 -987,600,000.00 8,146,730,000.00 8,910,660,000.00 8,444,300,000.00 466,360,000.00 112,700,000.00 353,660,000.00
2023-09-30T00:00:00 quarterly 499,145,736.00 499,145,736.00 290,650,000.00 25,026,060,000.00 25,259,790,000.00 19,972,100,000.00 25,026,060,000.00 290,650,000.00 25,259,790,000.00 25,259,790,000.00 25,259,810,000.00 20,000.00 25,259,790,000.00 20,268,330,000.00 0.00 0.00 4,991,460,000.00 4,991,460,000.00 10,022,950,000.00 567,210,000.00 0.00 177,690,000.00 155,690,000.00 155,690,000.00 233,830,000.00 9,455,740,000.00 541,430,000.00 134,960,000.00 134,960,000.00 0.00 0.00 82,450,000.00 4,490,940,000.00 0.00 0.00 92,230,000.00 4,398,710,000.00 35,282,760,000.00 5,854,920,000.00 35,000,000.00 0.00 0.00 215,890,000.00 0.00 215,890,000.00 0.00 233,730,000.00 233,730,000.00 0.00 5,014,260,000.00 0.00 5,014,260,000.00 233,540,000.00 4,780,720,000.00 0.00 0.00 0.00 0.00 29,427,840,000.00 1,054,900,000.00 0.00 0.00 0.00 5,616,610,000.00 0.00 0.00 0.00 0.00 6,980,000.00 8,679,450,000.00 0.00 0.00 14,069,900,000.00 13,562,770,000.00 507,130,000.00 0.00 0.00
2023-03-31T00:00:00 quarterly 499,145,736.00 499,145,736.00 339,720,000.00 23,602,270,000.00 23,817,800,000.00 18,545,500,000.00 23,602,270,000.00 339,720,000.00 23,817,800,000.00 23,817,800,000.00 23,817,820,000.00 20,000.00 23,817,800,000.00 18,826,340,000.00 1,637,210,000.00 2,350,600,000.00 4,991,460,000.00 4,991,460,000.00 9,869,320,000.00 539,340,000.00 225,630,000.00 136,260,000.00 177,450,000.00 177,450,000.00 0.00 9,329,980,000.00 512,240,000.00 162,270,000.00 162,270,000.00 0.00 63,070,000.00 0.00 5,493,450,000.00 553,360,000.00 9,570,000.00 28,380,000.00 4,902,140,000.00 33,687,140,000.00 5,811,660,000.00 250,000.00 444,820,000.00 0.00 1,150,000.00 0.00 1,150,000.00 0.00 215,530,000.00 215,530,000.00 0.00 4,794,400,000.00 -2,256,790,000.00 7,051,190,000.00 534,690,000.00 171,350,000.00 3,868,980,000.00 1,483,380,000.00 992,790,000.00 0.00 27,875,480,000.00 1,261,490,000.00 15,700,000.00 2,559,570,000.00 3,598,840,000.00 8,886,970,000.00 316,040,000.00 4,276,870,000.00 454,620,000.00 3,839,440,000.00 268,800,000.00 9,460,620,000.00 -879,330,000.00 10,339,950,000.00 3,084,980,000.00 2,616,070,000.00 468,910,000.00 236,800,000.00 232,110,000.00
2023-03-31T00:00:00 annual 499,145,736.00 499,145,736.00 339,720,000.00 23,602,270,000.00 23,817,800,000.00 18,545,500,000.00 23,602,270,000.00 339,720,000.00 23,817,800,000.00 23,817,800,000.00 23,817,820,000.00 20,000.00 23,817,800,000.00 18,826,340,000.00 1,637,210,000.00 2,350,600,000.00 4,991,460,000.00 4,991,460,000.00 9,869,320,000.00 539,340,000.00 225,630,000.00 136,260,000.00 177,450,000.00 177,450,000.00 0.00 9,329,980,000.00 512,240,000.00 162,270,000.00 162,270,000.00 0.00 63,070,000.00 0.00 5,493,450,000.00 553,360,000.00 9,570,000.00 28,380,000.00 4,902,140,000.00 33,687,140,000.00 5,811,660,000.00 250,000.00 444,820,000.00 0.00 1,150,000.00 0.00 1,150,000.00 0.00 215,530,000.00 215,530,000.00 0.00 4,794,400,000.00 -2,256,790,000.00 7,051,190,000.00 534,690,000.00 171,350,000.00 3,868,980,000.00 1,483,380,000.00 992,790,000.00 0.00 27,875,480,000.00 1,261,490,000.00 15,700,000.00 2,559,570,000.00 3,598,840,000.00 8,886,970,000.00 316,040,000.00 4,276,870,000.00 454,620,000.00 3,839,440,000.00 268,800,000.00 9,460,620,000.00 -879,330,000.00 10,339,950,000.00 3,084,980,000.00 2,616,070,000.00 468,910,000.00 236,800,000.00 232,110,000.00
2022-03-31T00:00:00 annual 499,145,736.00 499,145,736.00 375,840,000.00 19,087,550,000.00 19,272,100,000.00 15,005,840,000.00 19,087,550,000.00 375,840,000.00 19,272,100,000.00 19,272,100,000.00 19,272,120,000.00 20,000.00 19,272,100,000.00 14,280,640,000.00 1,631,940,000.00 2,350,600,000.00 4,991,460,000.00 4,991,460,000.00 10,824,130,000.00 609,680,000.00 223,420,000.00 139,070,000.00 247,190,000.00 247,190,000.00 223,420,000.00 10,214,450,000.00 797,650,000.00 128,650,000.00 128,650,000.00 0.00 71,640,000.00 71,640,000.00 5,917,510,000.00 688,420,000.00 9,780,000.00 47,420,000.00 5,171,890,000.00 30,096,250,000.00 4,875,960,000.00 -110,000.00 95,270,000.00 0.00 301,140,000.00 0.00 301,140,000.00 0.00 184,550,000.00 184,550,000.00 0.00 4,071,280,000.00 -1,804,890,000.00 5,876,170,000.00 211,100,000.00 134,110,000.00 3,202,520,000.00 1,348,140,000.00 980,300,000.00 0.00 25,220,290,000.00 10,000.00 11,180,000.00 13,760,000.00 1,277,630,000.00 9,377,620,000.00 359,660,000.00 5,538,440,000.00 656,840,000.00 2,822,680,000.00 354,780,000.00 8,431,250,000.00 -670,250,000.00 9,101,500,000.00 5,754,070,000.00 5,181,610,000.00 572,460,000.00 201,300,000.00 371,160,000.00
2021-03-31T00:00:00 annual 499,145,736.00 499,145,736.00 326,350,000.00 15,306,270,000.00 15,412,000,000.00 12,233,100,000.00 15,306,270,000.00 326,350,000.00 15,412,000,000.00 15,412,000,000.00 15,413,010,000.00 1,010,000.00 15,412,000,000.00 10,420,540,000.00 1,517,900,000.00 2,350,600,000.00 4,991,460,000.00 4,991,460,000.00 11,306,250,000.00 495,770,000.00 292,040,000.00 50,400,000.00 153,330,000.00 153,330,000.00 292,040,000.00 10,810,480,000.00 1,081,920,000.00 173,020,000.00 173,020,000.00 0.00 56,260,000.00 2,804,430,000.00 6,871,440,000.00 932,220,000.00 8,300,000.00 18,450,000.00 5,912,470,000.00 26,719,260,000.00 3,675,680,000.00 175,660,000.00 175,660,000.00 0.00 53,440,000.00 30,000.00 53,440,000.00 1,460,000.00 105,730,000.00 105,730,000.00 0.00 3,129,660,000.00 -1,420,520,000.00 4,550,180,000.00 42,540,000.00 126,860,000.00 2,974,870,000.00 1,108,710,000.00 297,200,000.00 0.00 23,043,580,000.00 280,000.00 11,150,000.00 12,510,000.00 1,539,160,000.00 7,543,630,000.00 369,940,000.00 4,050,350,000.00 435,690,000.00 2,687,650,000.00 128,240,000.00 8,482,440,000.00 -440,250,000.00 8,922,690,000.00 5,326,170,000.00 3,443,110,000.00 1,883,060,000.00 1,542,500,000.00 340,560,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,764,590,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10,910,000.00 0.00 30,000.00 0.00 1,230,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: SUMICHEM Cash Flow Data In (Cr)

date period_type Free Cash Flow Repayment Of Debt Issuance Of Debt Capital Expenditure End Cash Position Other Cash Adjustment Outside Changein Cash Beginning Cash Position Changes In Cash Financing Cash Flow Net Other Financing Charges Interest Paid Cff Cash Dividends Paid Common Stock Dividend Paid Net Issuance Payments Of Debt Net Short Term Debt Issuance Short Term Debt Payments Short Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Dividends Received Cfi Net Investment Purchase And Sale Sale Of Investment Purchase Of Investment Net Business Purchase And Sale Purchase Of Business Net PPE Purchase And Sale Sale Of PPE Purchase Of PPE Capital Expenditure Reported Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Liabilities Change In Other Current Assets Change In Payable Change In Inventory Change In Receivables Other Non Cash Items Provisionand Write Offof Assets Depreciation And Amortization Amortization Cash Flow Depreciation Gain Loss On Investment Securities Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Net Income From Continuing Operations
2024-03-31T00:00:00 annual 6,934,290,000.00 -53,480,000.00 5,060,000.00 -637,430,000.00 466,360,000.00 0.00 468,910,000.00 -2,550,000.00 -3,370,490,000.00 28,750,000.00 -15,160,000.00 -3,098,160,000.00 0.00 -53,480,000.00 -53,480,000.00 -53,480,000.00 5,060,000.00 -4,203,780,000.00 0.00 462,020,000.00 0.00 -3,468,260,000.00 15,940,310,000.00 -19,408,570,000.00 -578,530,000.00 -578,530,000.00 -619,010,000.00 18,420,000.00 -637,430,000.00 0.00 7,571,720,000.00 -1,290,430,000.00 3,899,630,000.00 -711,800,000.00 216,690,000.00 -634,050,000.00 2,817,420,000.00 2,138,860,000.00 -538,900,000.00 -57,560,000.00 621,890,000.00 35,460,000.00 586,430,000.00 -331,320,000.00 -1,320,000.00 -2,140,000.00 5,029,480,000.00
2023-03-31T00:00:00 annual 2,695,010,000.00 0.00 0.00 -1,198,840,000.00 468,910,000.00 0.00 572,460,000.00 -103,550,000.00 -725,450,000.00 0.00 -15,420,000.00 -499,360,000.00 0.00 0.00 0.00 0.00 0.00 -3,271,950,000.00 0.00 139,320,000.00 0.00 -2,215,910,000.00 13,304,410,000.00 -15,520,320,000.00 0.00 0.00 -1,195,360,000.00 3,480,000.00 -1,198,840,000.00 0.00 3,893,850,000.00 -1,681,090,000.00 -1,351,660,000.00 -573,500,000.00 212,500,000.00 -268,180,000.00 490,650,000.00 -1,233,940,000.00 -195,410,000.00 -4,370,000.00 518,780,000.00 28,940,000.00 489,840,000.00 -166,050,000.00 -1,280,000.00 1,320,000.00 6,541,760,000.00
2022-03-31T00:00:00 annual 1,082,620,000.00 0.00 0.00 -1,135,190,000.00 572,460,000.00 0.00 1,883,060,000.00 -1,310,600,000.00 -626,380,000.00 0.00 -14,490,000.00 -400,180,000.00 0.00 0.00 0.00 0.00 0.00 -2,902,030,000.00 0.00 58,880,000.00 0.00 -1,836,350,000.00 5,965,710,000.00 -7,802,060,000.00 0.00 0.00 -1,124,560,000.00 10,630,000.00 -1,135,190,000.00 0.00 2,217,810,000.00 -1,426,070,000.00 -2,277,820,000.00 133,440,000.00 46,780,000.00 -756,470,000.00 -1,833,990,000.00 149,250,000.00 -340,370,000.00 -2,080,000.00 448,140,000.00 0.00 448,140,000.00 -145,180,000.00 -33,610,000.00 -4,040,000.00 5,757,310,000.00
2021-03-31T00:00:00 annual 3,821,470,000.00 0.00 0.00 -432,640,000.00 1,883,060,000.00 -170,000.00 926,140,000.00 956,920,000.00 -470,640,000.00 0.00 -14,580,000.00 -275,150,000.00 0.00 0.00 0.00 0.00 0.00 -2,826,550,000.00 0.00 99,520,000.00 0.00 -2,497,850,000.00 3,950,840,000.00 -6,448,690,000.00 0.00 0.00 -428,220,000.00 4,420,000.00 -432,640,000.00 0.00 4,254,110,000.00 -1,079,370,000.00 255,600,000.00 1,424,030,000.00 -417,520,000.00 1,083,920,000.00 -1,663,590,000.00 -188,760,000.00 -43,970,000.00 -6,270,000.00 465,830,000.00 0.00 465,830,000.00 -73,750,000.00 -1,910,000.00 -290,000.00 4,532,990,000.00
2020-03-31T00:00:00 annual 0.00 -197,450,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -46,940,000.00 0.00 0.00 -215,240,000.00 -197,450,000.00 -197,450,000.00 -197,450,000.00 0.00 0.00 -390,000.00 0.00 3,950,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -379,990,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: SUMICHEM Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Minority Interests Net Income Including Noncontrolling Interests Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Special Income Charges Other Special Charges Write Off Impairment Of Capital Assets Restructuring And Mergern Acquisition Net Non Operating Interest Income Expense Total Other Finance Cost Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Research And Development Selling General And Administration Selling And Marketing Expense General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue
2024-03-31T00:00:00 annual 6.52 0.00 544.12 24.61 24.61 369.54 62.19 1,798.61 568.73 506.54 53.30 3.59 59.00 351.45 369.54 2,396.06 5.10 49.91 49.91 0.00 0.00 369.54 369.54 0.00 369.54 -0.20 369.74 369.74 133.20 502.95 3.14 -8.52 -5.97 14.49 0.00 0.00 53.30 2.10 3.59 59.00 421.71 597.45 159.22 62.19 3.55 58.64 1.34 121.24 98.85 22.39 5.10 1,019.16 1,798.61 2,817.77 2,817.77
2023-03-31T00:00:00 annual 3.90 0.00 693.13 16.78 16.78 502.21 51.88 2,285.49 709.91 658.03 18.73 3.85 24.94 489.33 502.21 2,857.99 3.93 49.91 49.91 0.00 0.00 502.21 502.21 0.00 502.21 0.00 502.21 502.21 151.97 654.18 1.76 0.18 -0.44 0.13 0.13 0.00 18.73 2.35 3.85 24.94 615.36 572.50 164.97 51.88 2.89 48.98 1.13 139.36 120.60 18.76 3.93 1,187.86 2,285.49 3,473.34 3,473.34
2022-03-31T00:00:00 annual 4.06 0.00 609.91 15.35 15.35 423.56 44.81 1,923.59 625.26 580.45 2.38 4.72 10.35 412.26 423.56 2,474.29 2.83 49.91 49.91 0.00 0.00 423.56 423.56 0.00 423.56 0.01 423.55 423.55 152.19 575.73 1.27 0.83 -0.86 0.00 0.03 0.00 2.38 3.26 4.72 10.35 561.61 550.70 150.88 44.81 0.00 44.81 1.20 146.35 130.67 15.68 2.83 1,112.31 1,923.59 3,035.90 3,035.90
2021-03-31T00:00:00 annual 1.91 0.00 495.94 8.04 8.04 345.31 46.58 1,669.17 503.98 457.40 3.03 4.10 9.95 339.18 345.31 2,179.02 3.22 49.91 49.91 0.00 0.00 345.31 345.31 0.00 345.31 -0.10 345.41 345.41 107.89 453.30 1.20 0.66 -0.66 20.52 0.00 0.00 3.03 2.83 4.10 9.95 444.29 509.86 126.99 46.58 0.00 46.58 0.78 130.55 101.37 29.18 3.22 954.15 1,669.17 2,623.32 2,623.32
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 30.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
5/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

9.67

P/E

53.190277

P/B

9.467144

Dividend Yield

1.35%

Market Cap

25,673.57 Cr.

Face Value

54.33

Book Value

54.33

ROE

15.88%

EBITDA Growth

591.33 Cr.

Debt/Equity

1.064

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

SUMICHEM News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

SUMICHEM News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

SUMICHEM News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

SUMICHEM News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

SUMICHEM News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

SUMICHEM News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

SUMICHEM News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

SUMICHEM News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy sumichem Shares on Fincept?

You can buy Sumitomo Chemical India Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of sumichem?

The market capitalization of Sumitomo Chemical India Limited is ₹25,674 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Sumitomo Chemical India Limited?

The PE and PB ratios of Sumitomo Chemical India Limited are Not Available and 9.467144 respectively as of 05 Feb 2025.

What is the 52 Week High of Sumitomo Chemical India Limited?

The 52-week high of Sumitomo Chemical India Limited is ₹628.3 as of 05 Feb 2025.

What is the 52 Week Low of Sumitomo Chemical India Limited?

The 52-week low of Sumitomo Chemical India Limited is ₹336.1 as of 05 Feb 2025.

What are the earnings per share (EPS) for Sumitomo Chemical India Limited?

The Earnings Per Share (EPS) of Sumitomo Chemical India Limited is ₹9.67 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Sumitomo Chemical India Limited?

The Return on Equity (ROE) of Sumitomo Chemical India Limited is 15.88% as per the most recent financial year data. Explore more on Fincept.

IDEA

View Stock

BANKBARODA

View Stock

AKZOINDIA

View Stock

DENORA

View Stock

IDFCFIRSTB

View Stock

SHRIPISTON

View Stock

MADRASFERT

View Stock

TVSHLTD

View Stock

RENUKA

View Stock

DHANBANK

View Stock

TTKPRESTIG

View Stock

NOIDATOLL

View Stock

ANDHRSUGAR

View Stock

WOCKPHARMA

View Stock

HINDMOTORS

View Stock